Treatment of Insomnia in a 75-Year-Old Female
Cognitive Behavioral Therapy for Insomnia (CBT-I) should be the first-line treatment for this elderly patient with insomnia, as it is effective, has minimal side effects, and provides long-term benefits compared to pharmacological options. 1
Initial Approach: Non-Pharmacological Interventions
Cognitive Behavioral Therapy for Insomnia (CBT-I)
CBT-I is strongly recommended as the initial treatment for chronic insomnia in older adults based on moderate-quality evidence showing improvements in both global sleep outcomes and specific sleep parameters 1. The components include:
Cognitive therapy: Addresses misconceptions about sleep and unrealistic expectations
Stimulus control:
- Go to bed only when sleepy
- Use bed only for sleep (not reading, watching TV)
- Leave bed if unable to fall asleep within 20 minutes
- Return to bed only when sleepy
- Maintain a regular wake-up time 1
Sleep restriction:
- Initially limit time in bed to actual sleep time (but not less than 5 hours)
- Gradually increase time in bed as sleep efficiency improves
- Particularly effective but requires careful implementation in elderly patients to avoid excessive daytime sleepiness 1
Relaxation training: Progressive muscle relaxation to reduce physical tension 1
Delivery Methods for CBT-I
For a 75-year-old female, consider these delivery options:
- Individual in-person sessions
- Group therapy
- Telephone-based sessions
- Web-based modules
- Self-help books 1
Pharmacological Options (Only If CBT-I Is Unsuccessful)
If CBT-I alone is unsuccessful after an adequate trial (typically 4-6 weeks), consider adding short-term pharmacotherapy using a shared decision-making approach that discusses benefits, risks, and costs 1.
Recommended Medication Sequence for Elderly Patients:
Low-dose doxepin (3-6 mg): Moderate-quality evidence shows improvement in sleep outcomes with fewer side effects than other options 1
Eszopiclone: Low-quality evidence shows improved global and sleep outcomes in older adults 1
Ramelteon: Low-quality evidence shows decreased sleep onset latency in older adults with fewer side effects than benzodiazepine receptor agonists 1, 2
Zolpidem (reduced dose of 5mg or less): Low-quality evidence shows decreased sleep onset latency, but use cautiously due to risk of falls, cognitive impairment, and "sleep driving" 1, 3
Important Cautions for Pharmacotherapy in Elderly
- Limit duration: FDA approves hypnotics only for short-term use (4-5 weeks) 1
- Use lower doses: Elderly patients require lower doses than those used in clinical trials 1
- Monitor for adverse effects: Especially falls, cognitive impairment, and daytime sedation 1
- Avoid benzodiazepines: Associated with increased risk of falls, fractures, cognitive impairment, and dependence 1, 3
- Avoid diphenhydramine and other OTC sleep aids: Limited evidence for efficacy and significant anticholinergic side effects in elderly 2
Follow-up and Monitoring
- Reassess every few weeks during active treatment
- Use sleep diaries to track progress
- Once stable, follow up every 6 months as relapse rates are high 1
- If treatment is ineffective, consider reevaluation for occult comorbid disorders 1
Common Pitfalls to Avoid
Relying solely on sleep hygiene: While important, sleep hygiene alone is insufficient for treating chronic insomnia and should be combined with other therapies 1
Long-term hypnotic use: Avoid prolonged use of sleep medications due to risks of dependence, tolerance, and adverse effects 1
Overlooking age-specific concerns: Elderly patients are more sensitive to medication side effects and require careful dosing adjustments 3
Ignoring comorbid conditions: Medical and psychiatric conditions common in elderly can exacerbate insomnia and require specific management 1
By following this evidence-based approach prioritizing CBT-I with judicious use of pharmacotherapy only when necessary, this 75-year-old female has the best chance of achieving improved sleep with minimal risks to her health and quality of life.